| Earnings Per Share [Text Block] |
Earnings Per Share Net earnings attributable to Procter & Gamble less preferred dividends (net of related tax benefits) are divided by the weighted average number of common shares outstanding during the period to calculate Basic net earnings per common share. Diluted net earnings per common share are calculated to give effect to stock options and other stock-based awards and assume conversion of preferred stock. Net earnings attributable to Procter & Gamble and common shares used to calculate Basic and Diluted net earnings per share were as follows: | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, 2016 | | Three Months Ended September 30, 2015 | CONSOLIDATED AMOUNTS | Continuing Operations | Discontinued Operations | Total | | Continuing Operations | Discontinued Operations | Total | Net earnings/(loss) | $ | 2,875 |
| $ | (118 | ) | $ | 2,757 |
| | $ | 2,777 |
| $ | (142 | ) | $ | 2,635 |
| Net earnings attributable to noncontrolling interests | (43 | ) | — |
| (43 | ) | | (34 | ) | — |
| (34 | ) | Net earnings/(loss) attributable to P&G (Diluted) | 2,832 |
| (118 | ) | 2,714 |
| | 2,743 |
| (142 | ) | 2,601 |
| Preferred dividends, net of tax benefit | (63 | ) | — |
| (63 | ) | | (65 | ) | — |
| (65 | ) | Net earnings/(loss) attributable to P&G available to common shareholders (Basic) | $ | 2,769 |
| $ | (118 | ) | $ | 2,651 |
| | $ | 2,678 |
| $ | (142 | ) | $ | 2,536 |
| | | | | | | | | SHARES IN MILLIONS | | | | | | | | Basic weighted average common shares outstanding | 2,674.7 |
| 2,674.7 |
| 2,674.7 |
| | 2,720.1 |
| 2,720.1 |
| 2,720.1 |
| Effect of dilutive securities | | | | | | | | Conversion of preferred shares (1) | 101.0 |
| 101.0 |
| 101.0 |
| | 105.7 |
| 105.7 |
| 105.7 |
| Exercise of stock options and other unvested equity awards (2) | 47.2 |
| 47.2 |
| 47.2 |
| | 41.7 |
| 41.7 |
| 41.7 |
| Diluted weighted average common shares outstanding | 2,822.9 |
| 2,822.9 |
| 2,822.9 |
| | 2,867.5 |
| 2,867.5 |
| 2,867.5 |
| | | | | | | | | PER SHARE AMOUNTS (3) | | | | | | | | Basic net earnings/(loss) per common share | $ | 1.03 |
| $ | (0.04 | ) | $ | 0.99 |
| | $ | 0.98 |
| $ | (0.05 | ) | $ | 0.93 |
| Diluted net earnings/(loss) per common share | $ | 1.00 |
| $ | (0.04 | ) | $ | 0.96 |
| | $ | 0.96 |
| $ | (0.05 | ) | $ | 0.91 |
|
| | (1) | Despite being included currently in Diluted net earnings per common share, the actual conversion to common stock occurs when the preferred shares are sold. Shares may only be sold after being allocated to the ESOP participants pursuant to the repayment of the ESOP's obligations through 2035. |
| | (2) | Outstanding stock options of approximately 26 million and 69 million for the three months ended September 30, 2016 and 2015, respectively, were not included in the Diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the total proceeds upon exercise would have exceeded the market value of the underlying common shares). |
| | (3) | Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings/(loss) attributable to Procter & Gamble. |
|